Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for ArriVent BioPharma, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
MC
Montanova Capital, LLC
|
4.5M | 9.12% | +114.4K (+2.6%) | 2024 | 2.9% | |
|
Shares held by quarter
Peak holding4.5M (Q2'26)
Change over 8 quarters+2.7M
Share of the company9.120%
|
||||||
|
IA
Infinitum Asset Management, LLC
|
4.4M | 8.96% | +289.5K (+7.0%) | 2024 | 15.7% | |
|
Shares held by quarter
Peak holding4.4M (Q2'26)
Change over 8 quarters+4.4M
Share of the company8.960%
|
||||||
28 more super investors behind a free account
See every manager holding ArriVent BioPharma, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$46.5M | 1.3M | 2.70% | 0.00% | June 30, 2026 |
|
SB
Fidelity Select Portfolios
|
$39.7M | 1.3M | 2.67% | 0.63% | August 31, 2026 |
23 more funds behind a free account
See every fund holding ArriVent BioPharma, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
HJ
Healy James
Insider
|
1.7M | 3.43% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company3.430%
|
||||||
|
GC
Gordon Carl L
Insider
|
1.5M | 3.06% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company3.060%
|
||||||
5 more holders behind a free account
See every insider and 5%+ holder of ArriVent BioPharma, Inc..
Sign up freeLoading...